| Literature DB >> 34945240 |
Alicja Jurecka1, Maciej Papież2, Paulina Skucińska3, Artur Gądek1.
Abstract
The term "soft tissue therapy" (STT) refers to mechanical methods of treatment involving passive kneading, pressing and stretching of pathologically tense tissues in supporting the process of recovery after surgery or trauma to the musculoskeletal system. The objective of this study was to review current scientific reports evaluating the effectiveness of the use of STT in patients with diseases or after surgical procedures of the knee joint. A systematic search of the popular scientific databases PubMed, Scopus and Embase was performed from inception to 15 October 2021. Eight articles met eligibility criteria and were included in the review. Six papers were related to disorders of the knee joint, while the remaining two studies were related to dysfunctions associated with the conditions after surgical intervention. The findings presented confirmed the effectiveness of STT in orthopaedic patients who showed an increase in lower limb functional parameters. The research has shown that the use of various methods of STT has a significant impact on increasing muscle activity and flexibility as well as increasing the range of motion in the knee joint. The physiotherapeutic methods used had a significant impact on reducing pain and increasing physical function and quality of life. The techniques used reduced the time to descend stairs in patients with knee osteoarthritis. This review summarises the effectiveness of STT as an important form of treatment for orthopaedic patients with various knee joint dysfunctions.Entities:
Keywords: fascial manipulation; lower limb; manual therapy; muscular stretching; musculoskeletal disorders; myofascial release; pain
Year: 2021 PMID: 34945240 PMCID: PMC8704673 DOI: 10.3390/jcm10245944
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Search criteria based on the PICO model.
| PICO | Description |
|---|---|
| Population | Orthopaedic patients (with dysfunctions of knee joint due to injury, disease or after surgery), children and adults of both sexes |
| Intervention | Treatment process involved in using a soft tissue physiotherapy method |
| Comparison | Period before and after applied treatment process |
| Outcomes | Effects of applied physiotherapeutic methods include, but are not limited to, improvement in knee joint function (including an increase in active and/or passive range of motion), an increase in muscle activity and strength, a reduction in excessive muscle tone and pain |
Summary of search strategies in PubMed, Scopus and Embase databases.
| Search—Database | Query Combination |
|---|---|
| #1—PubMed | “fascial manipulation” OR “fascial mobilization” OR “fascial therapy” OR “soft tissue manipulation” OR “soft tissue mobilization” OR “soft tissue therapy” AND “pain” |
| #4—Summary | #1 AND #2 AND #3 |
Figure 1PRISMA flow diagram for search strategy results and eligibility criteria.
Study characteristics.
| Author, Year | Participant Characteristics | Interventions/Number of Treatment Sessions | Outcome Measures | Main Findings (Pre vs. after the Treatment) | |||
|---|---|---|---|---|---|---|---|
|
| Age (Years) | Diagnosis/Patient’s Condition | |||||
| Argut, S.K. 2021 [ | IG = 21; CG = 21 | IG = 17:4; CG = 20:1 | IG = 69.3 ± 7.4; CG = 67.5 ± 5.01 | Total knee arthroplasty | IG: 1. Strengthening and stretching lower limb muscles and functional exercises (transfers, stair climbing); | NPRS | After the treatment: significant ↓ in pain in IG compared to CG ( |
| ROM | Knee flexion after the treatment: significant ↑ in ROM in IG compared to CG ( | ||||||
| WOMAC | After the treatment: significant ↓ in average WOMAC total score (pain, stiffness, function) in IG compared to CG ( | ||||||
| SF-12 MCS | After the treatment: significant ↑ in the mean value of the total quality of life score in the IG compared to CG ( | ||||||
| Cruz-Montecinos, C. 2016 [ | IG = 8; CG = 8 | IG = 8:0; CG = 8:0 | IG = 64.37 ± 2.9; CG = 61 ± 1.9 | Knee osteoarthritis | IG: soft tissue therapy including: muscular stretching of the psoas iliacus, hamstring, quadriceps, adductors, gastrocnemius and tensor fascia lata, joint mobilizations, and periarticular band tensing; | NPRS | After the treatment: significant ↓ in pain in IG compared to ( |
| EMG (sEMG) | After the treatment: significant ↓ in activity of the vastus lateralis muscle in IG compared to CG ( | ||||||
| WOMAC | After the treatment: a significant correlation between pain and change in co-contraction for the vastus lateralis muscle was noted in the IG (r = 0.804; | ||||||
| Stair descent time cycle [s] | After the treatment: significant ↓ in stair descend time in IG compared to CG ( | ||||||
| Goślińska, J. 2020 [ | EG = 27; MG = 27; CG = 27 | N/S | EG = 65.0 ± 7.4; MG = 66.1 ± 4.7; CG = 63.0 ± 6.6 | Knee osteoarthritis | EG: synergy and balance exercises in a closed kinematic chain; | Joint position sense (Orthyo System) | After the treatment: significant ↑ in values regarding the end angle in the left knee flexion position in MG compared to the other study groups ( |
| WOMAC | After the treatment: significant ↓ in average WOMAC total score (pain, stiffness, function) in EG and MG compared to CG ( | ||||||
| VAS | After the treatment: significant ↓ in pain in both lower limbs in EG and MG ( | ||||||
| Telles, G. 2016 [ | MG = 9; | N/S | MG = 63.3 ± 12.1 | Patellofemoral pain syndrome | MG: 1. Exercises to strengthen hip muscles, home exercises; 2. Myofascial release applied to the rectus femoris and tensor fascia lata muscle, and iliotibial band; | NPRS | After the treatment: significant ↓ in pain in MG compared to EG ( |
| LEFS | After the treatment: significant ↑ in physical function score in MG compared to EG ( | ||||||
| Donoso-Ubeda, E. 2018 [ | IG = 8;CG = 8 | N/S | IG = 39 ± 13.02; | Hemophilic arthropathy of the knee | IG: myofascial therapy including: superficial sliding anterior and posterior part of the leg combined with active flexion and extension movements of the foot, popliteal fascia, hands crossed technique applied to the anterior compartment of the knee, and degravitation and slight traction of the lower limb; | ROM | Knee flexion after the treatment: significant ↑ in ROM of both lower limbs in IG compared to CG ( |
| VAS | After the treatment: significant ↓ in pain of the right lower limb in IG compared to CG ( | ||||||
| E Silva, D.C.C.M. 2018 [ | 33 | 22:11 | 68.2 ± 7.85 | Total knee arthroplasty | Myofascial release including: gluteal fascia, posterior fascia lata, posterior crural fascia, and plantar fascia; | ROM | Knee flexion after the treatment: significant ↑ in ROM ( |
| EMG (sEMG) | After the treatment: significant ↑ in activity of the biceps femoris ( | ||||||
| VAS | 22 study participants reported no pain before treatment; | ||||||
| Padrelli, A. 2009 [ | 18 | 5:13 | 29.2 | Patellar tendinopathy | Fascial manipulation including CC points: AN-GE, ER-GE, IR-GE, LA-GE, ME-GE, and RE-GE; | VAS | After the treatment: significant ↓ in pain ( |
| Winslow, J. 2014 [ | 4 | 4:0 | 27–43 | Lateral knee pain syndrome | Soft tissue mobilization technique including: anterior and posterior border of the iliotibial band, vastus lateralis, biceps femoris, distal end of the hamstring, and gastrocnemius; | KEA | After the treatment: ↑ in flexibility of the hamstring and iliotibial band; |
| LEFS | After the treatment: ↑ in physical function score; three athletes who were able to run without pain improved their overall performance by 9–19 points; | ||||||
| GRCS | After the treatment: ↑ in overall athlete score by three to five points (improved); | ||||||
| NPRS | After the treatment: ↓ in pain; two athletes reported no pain at all, one athlete rated his pain as 1/10 points; one subject experienced lateral knee pain after running 0.3 miles, which he rated as 9/10 points | ||||||
n—number of participants, f—females, m—males, EG—Exercise Group, IG—Intervention Group, MG—Manual Group, N/S—Not Stated, CC—Centre of Coordination, AN-GE—ante-genu, ER-GE—extra-genu, IR-GE—intra-genu, LA-GE—latero-genu, ME-GE—medio-genu, RE-GE—retro-genu, EMG—Electromyography, sEMG—surface Electromyography, GRCS—Global Rating of Change Scale, KEA—Knee Extension Angle, LEFS—Lower Extremity Functional Scale, NPRS—Numeric Pain Rating Scale, ROM—Range of Motion, SF-12 MCS—Short Form-12 Mental Components, VAS—Visual Analog Scale, WOMAC—Western Ontario and McMaster Universities Osteoarthritis Index, d—effect size, p—value, r—correlation coefficient, ↓—decrease, ↑—increase.
Critical appraisal of randomized controlled trials.
| Author, Year | Was True Randomization Used for Assignment of Participants to Treatment Groups? | Was Allocation to Treatment Groups Concealed? | Were Treatment Groups Similar at the Baseline? | Were Participants Blind to Treatment Assignment? | Were Those Delivering Treatment Blind to Treatment Assignment? | Were Outcomes Assessors Blind to Treatment Assignment? | Were Treatment Groups Treated Identically Other Than the Intervention of Interest? | Was Follow up Complete and if not, Were Differences between Groups in Terms of Their Follow up Adequately Described and Analyzed? | Were Participants Analyzed in the Groups to Which They Were Randomized? | Were Outcomes Measured in the Same Way for Treatment Groups? | Were Outcomes Measured in a Reliable Way? | Was Appropriate Statistical Analysis Used? | Was the Trial Design Appropriate, and Any Deviations from the Standard RCT Design (Individual Randomization, Parallel Groups) Accounted for in the Conduct and Analysis of the Trial? | Johanna Briggs Institute Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Argut, S.K. 2021 [ | ✓ | ✓ | ✓ | ✓ | ✓ | X | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 12 |
| Cruz-Montecinos, C. 2016 [ | ✓ | ✓ | X | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 12 |
| Goślińska, J. 2020 [ | ✓ | ✓ | X | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 12 |
| Telles, G. 2016 [ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 13 |
✓—Yes, X—No.
Critical appraisal of non-randomized experimental studies.
| Author, Year | Is It Clear in the Study What Is the “Cause” and What Is the “Effect” (i.e., There Is No Confusion about Which Variable Comes First)? | Were the Participants Included in Any Comparisons Similar? | Were the Participants Included in Any Comparisons Receiving Similar Treatment/Care, Other than the Exposure or Intervention of Interest? | Was There a Control Group? | Were There Multiple Measurements of the Outcome Both Pre and Post the Intervention/Exposure? | Was Follow up Complete and If Not, Were Differences between Groups in Terms of Their Follow up Adequately Described and Analyzed? | Were the Outcomes of Participants Included in Any Comparisons Measured in the Same Way? | Were Outcomes Measured in a Reliable Way? | Was Appropriate Statistical Analysis Used? | Johanna Briggs Institute Score |
|---|---|---|---|---|---|---|---|---|---|---|
| Donoso-Ubeda, E. 2018 [ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | 9 |
| E Silva, D.C.C.M. 2018 [ | ✓ | ✓ | ✓ | X | ✓ | ✓ | ✓ | ✓ | ✓ | 8 |
| Padrelli, A. 2009 [ | ✓ | ✓ | ✓ | X | ✓ | ✓ | ✓ | ✓ | ✓ | 8 |
✓—Yes, X—No.
Critical appraisal of case series.
| Author, Year | Were There Clear Criteria for Inclusion in the Case Series? | Was the Condition Measured in a Standard, Reliable Way for All Participants Included in the Case Series? | Were Valid Methods Used for Identification of the Condition for All Participants Included in the Case Series? | Did the Case Series Have Consecutive Inclusion of Participants? | Did the Case Series Have Complete Inclusion of Participants? | Was There Clear Reporting of the Demographics of the Participants in the Study? | Was There Clear Reporting of Clinical Information of the Participants? | Were the Outcomes or Follow up Results of Cases Clearly Reported? | Was There Clear Reporting of the Presenting Site(s)/Clinic(s) Demographic Information? | Was Statistical Analysis Appropriate? | Johanna Briggs Institute Score |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Winslow, J. 2014 [ | X | ✓ | ✓ | X | X | X | X | ✓ | X | X | 3 |
✓—Yes, X—No.